|
Q4 2022
|
19 |
306,916 |
PCVX, I9SA.HA, VERA, HLVX
|
13F-HR
|
2/10/2023 |
000095012323001542 |
|
Q3 2022
|
19 |
292,475 |
PCVX, VERA, HLVX, ACET
|
13F-HR
|
11/10/2022 |
000095012322011475 |
|
Q2 2022
|
21 |
312,400 |
PCVX, Sierra Oncology, VERA, ACET
|
13F-HR
|
8/15/2022 |
000095012322008979 |
|
Q1 2022
|
20 |
352,495 |
PCVX, VERA, ACET, Sierra Oncology
|
13F-HR
|
5/16/2022 |
000095012322005945 |
|
Q4 2021
|
20 |
412,700 |
PCVX, VERA, JSPR, EFTR
|
13F-HR
|
2/16/2022 |
000095012322003174 |
|
Q3 2021
|
20 |
440,666 |
PCVX, EFTR, JSPR, VERA
|
13F-HR
|
11/15/2021 |
000095012321015091 |
|
Q2 2021
|
19 |
323,501 |
PCVX, PHAT, VERA, Spruce Bio
|
13F-HR
|
8/16/2021 |
000095012321011049 |
|
Q1 2021
|
17 |
289,551 |
PCVX, PHAT, Spruce Bio, ACET
|
13F-HR
|
5/17/2021 |
000095012321006642 |
|
Q4 2020
|
15 |
292,327 |
PCVX, Spruce Bio, PHAT, SLNO
|
13F-HR
|
3/1/2021 |
000095012321003195 |
|
Q3 2020
|
17 |
467,504 |
PCVX, PSNL, PHAT, SLNO
|
13F-HR
|
11/16/2020 |
000095012320011855 |
|
Q2 2020
|
16 |
357,663 |
PCVX, PSNL, PHAT, CRSP
|
13F-HR
|
8/14/2020 |
000095012320009033 |
|
Q1 2020
|
16 |
150,582 |
PSNL, PHAT, CRSP, SLNO
|
13F-HR
|
5/14/2020 |
000095012320004711 |
|
Q4 2019
|
16 |
206,909 |
PSNL, PHAT, CRSP, SIEN
|
13F-HR
|
2/14/2020 |
000095012320002010 |
|
Q3 2019
|
14 |
158,151 |
PSNL, CRSP, XCUR, SIEN
|
13F-HR
|
11/14/2019 |
000095012319010931 |
|
Q2 2019
|
14 |
260,762 |
PSNL, CRSP, SIEN, AVDR
|
13F-HR
|
8/14/2019 |
000095012319007879 |
|
Q1 2019
|
14 |
111,733 |
CRSP, SIEN, CHMA, SLNO
|
13F-HR
|
5/15/2019 |
000095012319004991 |
|
Q4 2018
|
16 |
110,057 |
CRSP, SIEN, I9SA.HA, SLNO
|
13F-HR
|
2/14/2019 |
000095012319001785 |
|
Q3 2018
|
16 |
168,201 |
CRSP, SIEN, I9SA.HA, PRTK
|
13F-HR
|
11/14/2018 |
000095012318011490 |
|
Q2 2018
|
16 |
175,043 |
CRSP, SIEN, PRTK, OBSV
|
13F-HR
|
8/14/2018 |
000095012318008483 |
|
Q1 2018
|
16 |
160,870 |
CRSP, SIEN, PRTK, ONCT
|
13F-HR
|
5/15/2018 |
000095012318005361 |
|
Q4 2017
|
17 |
138,016 |
CRSP, SIEN, PRTK, CBAY
|
13F-HR
|
2/14/2018 |
000095012318001868 |
|
Q3 2017
|
18 |
144,439 |
CRSP, SIEN, PRTK, CBAY
|
13F-HR
|
11/14/2017 |
000095012317010459 |
|
Q2 2017
|
16 |
125,658 |
CRSP, PRTK, SIEN, CBAY
|
13F-HR
|
8/14/2017 |
000095012317007534 |
|
Q1 2017
|
17 |
134,219 |
CRSP, PRTK, SIEN, CBAY
|
13F-HR
|
5/15/2017 |
000095012317004984 |
|
Q4 2016
|
18 |
119,631 |
CRSP, PRTK, SIEN, NOVN
|
13F-HR
|
2/14/2017 |
000095012317001929 |
|
Q3 2016
|
20 |
104,334 |
SIEN, TARA, PRTK, MLNT
|
13F-HR
|
11/14/2016 |
000095012316021952 |
|
Q2 2016
|
20 |
95,498 |
PRTK, TARA, SIEN, TBRA
|
13F-HR
|
8/12/2016 |
000095012316019505 |
|
Q1 2016
|
19 |
107,619 |
PRTK, CHMA, TARA, SIEN
|
13F-HR
|
5/13/2016 |
000095012316017004 |
|
Q4 2015
|
18 |
165,700 |
CHMA, TARA, PRTK, SIEN
|
13F-HR
|
2/16/2016 |
000095012316014690 |
|
Q3 2015
|
17 |
171,209 |
CHMA, TARA, PRTK, SIEN
|
13F-HR
|
11/13/2015 |
000095012315011710 |
|
Q2 2015
|
16 |
220,340 |
SIEN, TARA, PRTK, AMRN
|
13F-HR
|
8/14/2015 |
000095012315009063 |
|
Q1 2015
|
17 |
235,176 |
SIEN, PRTK, SUPN, DRNA
|
13F-HR
|
5/14/2015 |
000095012315005781 |
|
Q4 2014
|
16 |
352,088 |
RNA, PRTK, SIEN, PTLA
|
13F-HR
|
2/13/2015 |
000095012315001866 |
|
Q3 2014
|
13 |
167,253 |
RNA, EVARF, SUPN, PTLA
|
RESTATEMENT
|
11/25/2014 |
000095012314012543 |
|
Q2 2014
|
12 |
215,201 |
RNA, SUPN, PTLA, DRNA
|
13F-HR
|
8/14/2014 |
000095012314008800 |
|
Q1 2014
|
13 |
181,248 |
RNA, DRNA, SUPN, PTLA
|
13F-HR
|
5/21/2014 |
000095012314006465 |
|
Q4 2013
|
11 |
132,698 |
PTLA, RNA, SUPN, AMRN
|
13F-HR
|
2/14/2014 |
000095012314002352 |